
Sign up to save your podcasts
Or
I am delighted to welcome back John Hoffman to Between the Biotech Waves. John is managing director & head of healthcare equity capital markets at Credit Suisse. In mid 2022 John joined the podcast to discuss the market outlook for ’22 and many of his predictions were spot on. It was also one of the most downloaded podcasts of the year. I am welcoming him back to review ’22, lessons learned and crystal ball gaze into ’23. What are we seeing overall in the capital markets, is M&A now on the horizon and what should pre-IPO companies be thinking about.
4.9
2121 ratings
I am delighted to welcome back John Hoffman to Between the Biotech Waves. John is managing director & head of healthcare equity capital markets at Credit Suisse. In mid 2022 John joined the podcast to discuss the market outlook for ’22 and many of his predictions were spot on. It was also one of the most downloaded podcasts of the year. I am welcoming him back to review ’22, lessons learned and crystal ball gaze into ’23. What are we seeing overall in the capital markets, is M&A now on the horizon and what should pre-IPO companies be thinking about.
4,330 Listeners
1,715 Listeners
8,637 Listeners
4,223 Listeners
1,865 Listeners
1,999 Listeners
9,502 Listeners
316 Listeners
885 Listeners
87 Listeners
30 Listeners
144 Listeners
18 Listeners
49 Listeners
377 Listeners